{"nct_id":"NCT06632951","title":"Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2025-01-20","start_date_type":"ACTUAL","primary_completion_date":"2027-03","primary_completion_date_type":"ESTIMATED","completion_date":"2028-08","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}